Subject category:
Entrepreneurship
Published by:
IBS Case Development Center
Length: 13 pages
Data source: Published sources
Topics:
Industry-Academia rapport; UCSF fundamental research; UCSF-industry interaction; Business spin-offs from UCSF; Grants to UCSF; Genentech and Chiron; History of biotechnology; Inventions at UCSF; UCSF-industry collaborations and rapport; Funding of UCSF; UCSF the biotech hub; Collaborative research at UCSF; UCSF and California's economy; University of California, San Francisco; UCSF
Share a link:
https://casecent.re/p/21315
Write a review
|
No reviews for this item
This product has not been used yet
Abstract
University of California, San Francisco (UCSF), in its 130-year history, had traditionally served as a regional medical institution for training competent doctors to serve western USA. For years UCSF was considered to be an unlikely place for radical inventions. The scenario started changing from 1968 when collaborative approach to fundamental research started attracting some of the brightest scientific minds to UCSF. UCSF gave the world two of its largest biotech companies, Genentech and Chiron. By 2003, UCSF became a world leader in biomedical research with an annual budget of $1.9 billion besides being the largest employer in San Francisco. The case discusses how an ordinary medical institution transformed itself into a research powerhouse to become the world''s biomedical innovation hub.
About
Abstract
University of California, San Francisco (UCSF), in its 130-year history, had traditionally served as a regional medical institution for training competent doctors to serve western USA. For years UCSF was considered to be an unlikely place for radical inventions. The scenario started changing from 1968 when collaborative approach to fundamental research started attracting some of the brightest scientific minds to UCSF. UCSF gave the world two of its largest biotech companies, Genentech and Chiron. By 2003, UCSF became a world leader in biomedical research with an annual budget of $1.9 billion besides being the largest employer in San Francisco. The case discusses how an ordinary medical institution transformed itself into a research powerhouse to become the world''s biomedical innovation hub.